IBDEI01C ; ; 06-DEC-2010
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;DEC 06, 2010
 Q:'DIFQR(358.3)  F I=3D1:2 S X=3D$T(Q+I) Q:X=3D""  S
Y=3D$E($T(Q+I+1),4,999),X=3D$E(X,4,999) S:$A(Y)=3D126
I=3DI+1,Y=3D$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=3D61 Y=3D$E(Y,2,999) =
X NO E
S @X=3DY
Q Q
 ;;^UTILITY(U,$J,358.3,1562,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1562,1,4,0)
 ;;=3D4^397.0
 ;;^UTILITY(U,$J,358.3,1562,1,5,0)
 ;;=3D5^Rhem Tricuspid Valve Disease
 ;;^UTILITY(U,$J,358.3,1562,2)
 ;;=3D^35528
 ;;^UTILITY(U,$J,358.3,1563,0)
 ;;=3D424.90^^23^134^1
 ;;^UTILITY(U,$J,358.3,1563,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1563,1,4,0)
 ;;=3D4^424.90
 ;;^UTILITY(U,$J,358.3,1563,1,5,0)
 ;;=3D5^Endocarditis
 ;;^UTILITY(U,$J,358.3,1563,2)
 ;;=3D^40327
 ;;^UTILITY(U,$J,358.3,1564,0)
 ;;=3D996.02^^23^134^2
 ;;^UTILITY(U,$J,358.3,1564,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1564,1,4,0)
 ;;=3D4^996.02
 ;;^UTILITY(U,$J,358.3,1564,1,5,0)
 ;;=3D5^Mech Comp Valve Prosth
 ;;^UTILITY(U,$J,358.3,1564,2)
 ;;=3D^276265
 ;;^UTILITY(U,$J,358.3,1565,0)
 ;;=3DV43.3^^23^134^3
 ;;^UTILITY(U,$J,358.3,1565,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1565,1,4,0)
 ;;=3D4^V43.3
 ;;^UTILITY(U,$J,358.3,1565,1,5,0)
 ;;=3D5^S/P Artif Valve Replac
 ;;^UTILITY(U,$J,358.3,1565,2)
 ;;=3D^295440
 ;;^UTILITY(U,$J,358.3,1566,0)
 ;;=3DV45.89^^23^134^4
 ;;^UTILITY(U,$J,358.3,1566,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1566,1,4,0)
 ;;=3D4^V45.89
 ;;^UTILITY(U,$J,358.3,1566,1,5,0)
 ;;=3D5^S/P Valve Surgery
 ;;^UTILITY(U,$J,358.3,1566,2)
 ;;=3D^276679
 ;;^UTILITY(U,$J,358.3,1567,0)
 ;;=3D996.71^^23^134^5
 ;;^UTILITY(U,$J,358.3,1567,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1567,1,4,0)
 ;;=3D4^996.71
 ;;^UTILITY(U,$J,358.3,1567,1,5,0)
 ;;=3D5^Thrombus Valve Pros
 ;;^UTILITY(U,$J,358.3,1567,2)
 ;;=3D^276294
 ;;^UTILITY(U,$J,358.3,1568,0)
 ;;=3DV58.61^^23^134^4.5
 ;;^UTILITY(U,$J,358.3,1568,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1568,1,4,0)
 ;;=3D4^V58.61
 ;;^UTILITY(U,$J,358.3,1568,1,5,0)
 ;;=3D5^Long Term Use Anticoagulants
 ;;^UTILITY(U,$J,358.3,1568,2)
 ;;=3DLong Term Use Anticoagulants^303459
 ;;^UTILITY(U,$J,358.3,1569,0)
 ;;=3DV45.82^^23^134^6
 ;;^UTILITY(U,$J,358.3,1569,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1569,1,4,0)
 ;;=3D4^V45.82
 ;;^UTILITY(U,$J,358.3,1569,1,5,0)
 ;;=3D5^Status Post Angioplasty
 ;;^UTILITY(U,$J,358.3,1569,2)
 ;;=3D^303425
 ;;^UTILITY(U,$J,358.3,1570,0)
 ;;=3D284.9^^24^135^1
 ;;^UTILITY(U,$J,358.3,1570,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1570,1,1,0)
 ;;=3D1^284.9
 ;;^UTILITY(U,$J,358.3,1570,1,8,0)
 ;;=3D8^Aplastic Anemia
 ;;^UTILITY(U,$J,358.3,1570,2)
 ;;=3D^7020
 ;;^UTILITY(U,$J,358.3,1571,0)
 ;;=3D282.9^^24^135^2
 ;;^UTILITY(U,$J,358.3,1571,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1571,1,1,0)
 ;;=3D1^282.9
 ;;^UTILITY(U,$J,358.3,1571,1,8,0)
 ;;=3D8^Hemolytic Anemia,Hered
 ;;^UTILITY(U,$J,358.3,1571,2)
 ;;=3D^56578
 ;;^UTILITY(U,$J,358.3,1572,0)
 ;;=3D283.9^^24^135^3
 ;;^UTILITY(U,$J,358.3,1572,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1572,1,1,0)
 ;;=3D1^283.9
 ;;^UTILITY(U,$J,358.3,1572,1,8,0)
 ;;=3D8^Hemolytic Anemia,Acquired
 ;;^UTILITY(U,$J,358.3,1572,2)
 ;;=3D^7071
 ;;^UTILITY(U,$J,358.3,1573,0)
 ;;=3D283.0^^24^135^4
 ;;^UTILITY(U,$J,358.3,1573,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1573,1,1,0)
 ;;=3D1^283.0
 ;;^UTILITY(U,$J,358.3,1573,1,8,0)
 ;;=3D8^Hemolytic Anemia,Autoimmun
 ;;^UTILITY(U,$J,358.3,1573,2)
 ;;=3D^7079
 ;;^UTILITY(U,$J,358.3,1574,0)
 ;;=3D283.19^^24^135^5
 ;;^UTILITY(U,$J,358.3,1574,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1574,1,1,0)
 ;;=3D1^283.19
 ;;^UTILITY(U,$J,358.3,1574,1,8,0)
 ;;=3D8^Hemolytic Anemia,Microangiopathic
 ;;^UTILITY(U,$J,358.3,1574,2)
 ;;=3D^293664
 ;;^UTILITY(U,$J,358.3,1575,0)
 ;;=3D280.9^^24^135^6
 ;;^UTILITY(U,$J,358.3,1575,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1575,1,1,0)
 ;;=3D1^280.9
 ;;^UTILITY(U,$J,358.3,1575,1,8,0)
 ;;=3D8^Iron Defic Anemia
 ;;^UTILITY(U,$J,358.3,1575,2)
 ;;=3D^276946
 ;;^UTILITY(U,$J,358.3,1576,0)
 ;;=3D281.0^^24^135^9
 ;;^UTILITY(U,$J,358.3,1576,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1576,1,1,0)
 ;;=3D1^281.0
 ;;^UTILITY(U,$J,358.3,1576,1,8,0)
 ;;=3D8^Pernicious Anemia
 ;;^UTILITY(U,$J,358.3,1576,2)
 ;;=3D^7161
 ;;^UTILITY(U,$J,358.3,1577,0)
 ;;=3D285.9^^24^135^10
 ;;^UTILITY(U,$J,358.3,1577,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1577,1,1,0)
 ;;=3D1^285.9
 ;;^UTILITY(U,$J,358.3,1577,1,8,0)
 ;;=3D8^Unspecified Anemia
 ;;^UTILITY(U,$J,358.3,1577,2)
 ;;=3D^7007
 ;;^UTILITY(U,$J,358.3,1578,0)
 ;;=3D285.8^^24^135^7
 ;;^UTILITY(U,$J,358.3,1578,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1578,1,1,0)
 ;;=3D1^285.8
 ;;^UTILITY(U,$J,358.3,1578,1,8,0)
 ;;=3D8^Myelophthisic Anemia
 ;;^UTILITY(U,$J,358.3,1578,2)
 ;;=3D^87876
 ;;^UTILITY(U,$J,358.3,1579,0)
 ;;=3D281.8^^24^135^7
 ;;^UTILITY(U,$J,358.3,1579,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1579,1,1,0)
 ;;=3D1^281.8
 ;;^UTILITY(U,$J,358.3,1579,1,8,0)
 ;;=3D8^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,1579,2)
 ;;=3D^267979
 ;;^UTILITY(U,$J,358.3,1580,0)
 ;;=3D285.21^^24^135^.2
 ;;^UTILITY(U,$J,358.3,1580,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1580,1,1,0)
 ;;=3D1^285.21
 ;;^UTILITY(U,$J,358.3,1580,1,8,0)
 ;;=3D8^Anemia End-Stage Renal Disease
 ;;^UTILITY(U,$J,358.3,1580,2)
 ;;=3D^321977
 ;;^UTILITY(U,$J,358.3,1581,0)
 ;;=3D285.22^^24^135^.3
 ;;^UTILITY(U,$J,358.3,1581,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1581,1,1,0)
 ;;=3D1^285.22
 ;;^UTILITY(U,$J,358.3,1581,1,8,0)
 ;;=3D8^Anemia In Neoplastic Disease
 ;;^UTILITY(U,$J,358.3,1581,2)
 ;;=3D^321978
 ;;^UTILITY(U,$J,358.3,1582,0)
 ;;=3D285.29^^24^135^.4
 ;;^UTILITY(U,$J,358.3,1582,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1582,1,1,0)
 ;;=3D1^285.29
 ;;^UTILITY(U,$J,358.3,1582,1,8,0)
 ;;=3D8^Anemia Oth Chronic Illness
 ;;^UTILITY(U,$J,358.3,1582,2)
 ;;=3D^321979
 ;;^UTILITY(U,$J,358.3,1583,0)
 ;;=3D285.1^^24^135^6.5
 ;;^UTILITY(U,$J,358.3,1583,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1583,1,1,0)
 ;;=3D1^285.1
 ;;^UTILITY(U,$J,358.3,1583,1,8,0)
 ;;=3D8^Ac Posthemorrhag Anemia
 ;;^UTILITY(U,$J,358.3,1583,2)
 ;;=3D^267986
 ;;^UTILITY(U,$J,358.3,1584,0)
 ;;=3D286.9^^24^136^1
 ;;^UTILITY(U,$J,358.3,1584,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1584,1,1,0)
 ;;=3D1^286.9
 ;;^UTILITY(U,$J,358.3,1584,1,8,0)
 ;;=3D8^Defective Coagulation,Unspec
 ;;^UTILITY(U,$J,358.3,1584,2)
 ;;=3D^87267
 ;;^UTILITY(U,$J,358.3,1585,0)
 ;;=3D289.9^^24^136^4
 ;;^UTILITY(U,$J,358.3,1585,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1585,1,1,0)
 ;;=3D1^289.9
 ;;^UTILITY(U,$J,358.3,1585,1,8,0)
 ;;=3D8^Thrombocytosis,Essential
 ;;^UTILITY(U,$J,358.3,1585,2)
 ;;=3D^55344
 ;;^UTILITY(U,$J,358.3,1586,0)
 ;;=3D446.6^^24^136^5
 ;;^UTILITY(U,$J,358.3,1586,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1586,1,1,0)
 ;;=3D1^446.6
 ;;^UTILITY(U,$J,358.3,1586,1,8,0)
 ;;=3D8^Thrombocytopenic Purpura (T T P)
 ;;^UTILITY(U,$J,358.3,1586,2)
 ;;=3D^119061
 ;;^UTILITY(U,$J,358.3,1587,0)
 ;;=3D451.9^^24^136^6
 ;;^UTILITY(U,$J,358.3,1587,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1587,1,1,0)
 ;;=3D1^451.9
 ;;^UTILITY(U,$J,358.3,1587,1,8,0)
 ;;=3D8^Thrombophlebitis
 ;;^UTILITY(U,$J,358.3,1587,2)
 ;;=3D^93357
 ;;^UTILITY(U,$J,358.3,1588,0)
 ;;=3D287.5^^24^136^2.5
 ;;^UTILITY(U,$J,358.3,1588,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1588,1,1,0)
 ;;=3D1^287.5
 ;;^UTILITY(U,$J,358.3,1588,1,8,0)
 ;;=3D8^Thrombocytopenia Nos
 ;;^UTILITY(U,$J,358.3,1588,2)
 ;;=3D^118988
 ;;^UTILITY(U,$J,358.3,1589,0)
 ;;=3D287.1^^24^136^2.75
 ;;^UTILITY(U,$J,358.3,1589,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1589,1,1,0)
 ;;=3D1^287.1
 ;;^UTILITY(U,$J,358.3,1589,1,8,0)
 ;;=3D8^Qualitative Platelet Defects
 ;;^UTILITY(U,$J,358.3,1589,2)
 ;;=3D^101922
 ;;^UTILITY(U,$J,358.3,1590,0)
 ;;=3D287.30^^24^136^2
 ;;^UTILITY(U,$J,358.3,1590,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1590,1,1,0)
 ;;=3D1^287.30
 ;;^UTILITY(U,$J,358.3,1590,1,8,0)
 ;;=3D8^Prim Thrombocytopen Nos
 ;;^UTILITY(U,$J,358.3,1590,2)
 ;;=3D^332841
 ;;^UTILITY(U,$J,358.3,1591,0)
 ;;=3D287.49^^24^136^3
 ;;^UTILITY(U,$J,358.3,1591,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1591,1,1,0)
 ;;=3D1^287.49
 ;;^UTILITY(U,$J,358.3,1591,1,8,0)
 ;;=3D8^Thrombocytopenia,Drug Induced
 ;;^UTILITY(U,$J,358.3,1591,2)
 ;;=3D^339610
 ;;^UTILITY(U,$J,358.3,1592,0)
 ;;=3D205.00^^24^137^1
 ;;^UTILITY(U,$J,358.3,1592,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1592,1,1,0)
 ;;=3D1^205.00
 ;;^UTILITY(U,$J,358.3,1592,1,8,0)
 ;;=3D8^A M L, W/O Remission
 ;;^UTILITY(U,$J,358.3,1592,2)
 ;;=3D^267531
 ;;^UTILITY(U,$J,358.3,1593,0)
 ;;=3D205.01^^24^137^2
 ;;^UTILITY(U,$J,358.3,1593,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1593,1,1,0)
 ;;=3D1^205.01
 ;;^UTILITY(U,$J,358.3,1593,1,8,0)
 ;;=3D8^A M L,In Remission
 ;;^UTILITY(U,$J,358.3,1593,2)
 ;;=3D^267532
 ;;^UTILITY(U,$J,358.3,1594,0)
 ;;=3D205.10^^24^137^4
 ;;^UTILITY(U,$J,358.3,1594,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1594,1,1,0)
 ;;=3D1^205.10
 ;;^UTILITY(U,$J,358.3,1594,1,8,0)
 ;;=3D8^C M L,W/O Remission
 ;;^UTILITY(U,$J,358.3,1594,2)
 ;;=3D^267533
 ;;^UTILITY(U,$J,358.3,1595,0)
 ;;=3D205.11^^24^137^5
 ;;^UTILITY(U,$J,358.3,1595,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1595,1,1,0)
 ;;=3D1^205.11
 ;;^UTILITY(U,$J,358.3,1595,1,8,0)
 ;;=3D8^C M L,In Remission
 ;;^UTILITY(U,$J,358.3,1595,2)
 ;;=3D^267534
 ;;^UTILITY(U,$J,358.3,1596,0)
 ;;=3D289.0^^24^137^10
 ;;^UTILITY(U,$J,358.3,1596,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1596,1,1,0)
 ;;=3D1^289.0
 ;;^UTILITY(U,$J,358.3,1596,1,8,0)
 ;;=3D8^Secondary Polycythemia
 ;;^UTILITY(U,$J,358.3,1596,2)
 ;;=3D^186856
 ;;^UTILITY(U,$J,358.3,1597,0)
 ;;=3D238.4^^24^137^9
 ;;^UTILITY(U,$J,358.3,1597,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1597,1,1,0)
 ;;=3D1^238.4
 ;;^UTILITY(U,$J,358.3,1597,1,8,0)
 ;;=3D8^Polycythemia Rubra Vera
 ;;^UTILITY(U,$J,358.3,1597,2)
 ;;=3D^96105
 ;;^UTILITY(U,$J,358.3,1598,0)
 ;;=3D288.9^^24^137^11
 ;;^UTILITY(U,$J,358.3,1598,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1598,1,1,0)
 ;;=3D1^288.9
 ;;^UTILITY(U,$J,358.3,1598,1,8,0)
 ;;=3D8^Unspecified Dis Of W B C
 ;;^UTILITY(U,$J,358.3,1598,2)
 ;;=3D^267993
 ;;^UTILITY(U,$J,358.3,1599,0)
 ;;=3D289.89^^24^137^3
 ;;^UTILITY(U,$J,358.3,1599,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,1599,1,1,0)
 ;;=3D1^289.89
 ;;^UTILITY(U,$J,358.3,1599,1,8,0)
 ;;=3D8^Agnogenic Myeloid Metaplasia
 ;;^UTILITY(U,$J,358.3,1599,2)
 ;;=3D^329887
 ;;^UTILITY(U,$J,358.3,1600,0)
 ;;=3D238.75^^24^137^8
 ;;^UTILITY(U,$J,358.3,1600,1,0)
 ;;=3D^358.31IA^8^2
